Skip to main content
Premium Trial:

Request an Annual Quote

Roche, Entelos Pen 2-Year Alliance to Study Metabolic Diseases

NEW YORK, May 24 (GenomeWeb News) - Roche and Entelos have inked a two-year collaboration to research metabolic diseases, the companies said today.

 

Under the terms of the agreement, Roche will provide Entelos with R&D funding and milestone payments for biosimulation research conducted using its Metabolism PhysioLab platform, the companies said.

 

Roche said that Entelos' approach could be "useful in analyzing existing preclinical and clinical data in order to optimize future clinical trials" for drugs or tests that treat chronic metabolic disorders like diabetes and obesity.

 

Financial terms were not disclosed.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.